Although these findings seem to contradict an earlier study concluding that inactivation of both RD3 alleles in LCA12 patients does not correlate with extraocular symptoms [11], a more recent study supports the direct involvement of RD3 loss in neuroblastoma development and progression [15]. This evidence concerns the gene RD3 and neuroblastoma.